These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 17920565)

  • 1. Involvement of kappa-opioid and endocannabinoid system on Salvinorin A-induced reward.
    Braida D; Limonta V; Capurro V; Fadda P; Rubino T; Mascia P; Zani A; Gori E; Fratta W; Parolaro D; Sala M
    Biol Psychiatry; 2008 Feb; 63(3):286-92. PubMed ID: 17920565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hallucinatory and rewarding effect of salvinorin A in zebrafish: kappa-opioid and CB1-cannabinoid receptor involvement.
    Braida D; Limonta V; Pegorini S; Zani A; Guerini-Rocco C; Gori E; Sala M
    Psychopharmacology (Berl); 2007 Mar; 190(4):441-8. PubMed ID: 17219220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential anxiolytic- and antidepressant-like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents.
    Braida D; Capurro V; Zani A; Rubino T; Viganò D; Parolaro D; Sala M
    Br J Pharmacol; 2009 Jul; 157(5):844-53. PubMed ID: 19422370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delta9-tetrahydrocannabinol-induced conditioned place preference and intracerebroventricular self-administration in rats.
    Braida D; Iosuè S; Pegorini S; Sala M
    Eur J Pharmacol; 2004 Dec; 506(1):63-9. PubMed ID: 15588625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the plant-derived hallucinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in mice: agonist actions at kappa opioid receptors.
    Zhang Y; Butelman ER; Schlussman SD; Ho A; Kreek MJ
    Psychopharmacology (Berl); 2005 May; 179(3):551-8. PubMed ID: 15682306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the kappa opioid agonist R-84760 on cocaine-induced increases in striatal dopamine levels and cocaine-induced place preference in C57BL/6J mice.
    Zhang Y; Butelman ER; Schlussman SD; Ho A; Kreek MJ
    Psychopharmacology (Berl); 2004 Apr; 173(1-2):146-52. PubMed ID: 14712342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Learning and memory impairment induced by salvinorin A, the principal ingredient of Salvia divinorum, in wistar rats.
    Braida D; Donzelli A; Martucci R; Capurro V; Sala M
    Int J Toxicol; 2011 Dec; 30(6):650-61. PubMed ID: 21960665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kappa-opioid receptor-mediated effects of the plant-derived hallucinogen, salvinorin A, on inverted screen performance in the mouse.
    Fantegrossi WE; Kugle KM; Valdes LJ; Koreeda M; Woods JH
    Behav Pharmacol; 2005 Dec; 16(8):627-33. PubMed ID: 16286814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conditioned place preference induced by the cannabinoid agonist CP 55,940: interaction with the opioid system.
    Braida D; Pozzi M; Cavallini R; Sala M
    Neuroscience; 2001; 104(4):923-6. PubMed ID: 11457579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kappa-opioid receptor modulation of accumbal dopamine concentration during operant ethanol self-administration.
    Doyon WM; Howard EC; Shippenberg TS; Gonzales RA
    Neuropharmacology; 2006 Sep; 51(3):487-96. PubMed ID: 16781738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kappa opioid mediation of cannabinoid effects of the potent hallucinogen, salvinorin A, in rodents.
    Walentiny DM; Vann RE; Warner JA; King LS; Seltzman HH; Navarro HA; Twine CE; Thomas BF; Gilliam AF; Gilmour BP; Carroll FI; Wiley JL
    Psychopharmacology (Berl); 2010 Jun; 210(2):275-84. PubMed ID: 20354680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct evidence for the involvement of the mesolimbic kappa-opioid system in the morphine-induced rewarding effect under an inflammatory pain-like state.
    Narita M; Kishimoto Y; Ise Y; Yajima Y; Misawa K; Suzuki T
    Neuropsychopharmacology; 2005 Jan; 30(1):111-8. PubMed ID: 15257306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antinociceptive and hypothermic effects of Salvinorin A are abolished in a novel strain of kappa-opioid receptor-1 knockout mice.
    Ansonoff MA; Zhang J; Czyzyk T; Rothman RB; Stewart J; Xu H; Zjwiony J; Siebert DJ; Yang F; Roth BL; Pintar JE
    J Pharmacol Exp Ther; 2006 Aug; 318(2):641-8. PubMed ID: 16672569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats.
    Carlezon WA; Béguin C; DiNieri JA; Baumann MH; Richards MR; Todtenkopf MS; Rothman RB; Ma Z; Lee DY; Cohen BM
    J Pharmacol Exp Ther; 2006 Jan; 316(1):440-7. PubMed ID: 16223871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salvinorin A, an active component of the hallucinogenic sage salvia divinorum is a highly efficacious kappa-opioid receptor agonist: structural and functional considerations.
    Chavkin C; Sud S; Jin W; Stewart J; Zjawiony JK; Siebert DJ; Toth BA; Hufeisen SJ; Roth BL
    J Pharmacol Exp Ther; 2004 Mar; 308(3):1197-203. PubMed ID: 14718611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoid modulation of opiate reinforcement through the ventral striatopallidal pathway.
    Caillé S; Parsons LH
    Neuropsychopharmacology; 2006 Apr; 31(4):804-13. PubMed ID: 16123766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hallucinogen derived from Salvia divinorum, salvinorin A, has kappa-opioid agonist discriminative stimulus effects in rats.
    Willmore-Fordham CB; Krall DM; McCurdy CR; Kinder DH
    Neuropharmacology; 2007 Sep; 53(4):481-6. PubMed ID: 17681558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antinociceptive effect of salvinorin A in mice.
    John TF; French LG; Erlichman JS
    Eur J Pharmacol; 2006 Sep; 545(2-3):129-33. PubMed ID: 16905132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3,4 Methylenedioxymethamphetamine-induced conditioned place preference (CPP) is mediated by endocannabinoid system.
    Braida D; Iosuè S; Pegorini S; Sala M
    Pharmacol Res; 2005 Feb; 51(2):177-82. PubMed ID: 15629265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. kappa-Opioid receptor agonists prevent sensitization to the conditioned rewarding effects of cocaine.
    Shippenberg TS; LeFevour A; Heidbreder C
    J Pharmacol Exp Ther; 1996 Feb; 276(2):545-54. PubMed ID: 8632320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.